TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 46 filers reported holding TALIS BIOMEDICAL CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $67,454 | -4.7% | 140,530 | -2.7% | 0.00% | – |
Q1 2023 | $70,763 | +110467.2% | 144,416 | 0.0% | 0.00% | – |
Q4 2022 | $64 | -99.9% | 144,416 | -0.2% | 0.00% | – |
Q3 2022 | $98,000 | -16.2% | 144,746 | 0.0% | 0.00% | – |
Q2 2022 | $117,000 | -68.6% | 144,746 | -45.4% | 0.00% | – |
Q1 2022 | $373,000 | -67.0% | 264,904 | -5.9% | 0.00% | – |
Q4 2021 | $1,129,000 | -40.4% | 281,565 | -7.1% | 0.00% | – |
Q3 2021 | $1,893,000 | -33.5% | 302,968 | +17.4% | 0.00% | – |
Q2 2021 | $2,846,000 | -4.5% | 258,043 | +11.2% | 0.00% | – |
Q1 2021 | $2,981,000 | – | 232,026 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Greenlight Capital | 2,235,783 | $1,095,534 | 0.06% |
Baker Brothers Advisors | 7,624,835 | $3,736,169 | 0.02% |
PRELUDE CAPITAL MANAGEMENT, LLC | 223,934 | $109,728 | 0.01% |
ArrowMark Colorado Holdings LLC | 478,862 | $234,642 | 0.00% |
WELLS FARGO & COMPANY/MN | 167 | $82 | 0.00% |
NORTHERN TRUST CORP | 27,860 | $13,652 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 144,416 | $70,763 | 0.00% |
STATE STREET CORP | 49,536 | $24,273 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 163,663 | $80 | 0.00% |